Trial Results Search
Clinical Trial Results: Anemia
-
Protocol Number: ML20336
Product Name: Mircera [mehtoxy polyethylene glycol-epoetin beta]
Date of Report: 01.09.2008
Phase: III
-
Protocol Number: ML20338
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.08.2008
Phase: III
-
Protocol Number: MA16620
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: ML17912
Product Name: NeoRecormon® [epoetin beta]
Date of Report: 03.09.2007
Phase: IV
-
Protocol Number: ML18101
Product Name: NeoRecormon [epoetin beta]
Date of Report: 06.09.2006
Phase: IV
-
Protocol Number: ML18043
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.06.2009
Phase: IV
-
Protocol Number: ML20337
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.09.2008
Phase: III
-
Protocol Number: MO16375
Product Name: epoetin beta [epoetin beta]
Date of Report: 31.03.2005
Phase: III
-
Protocol Number: ML20339
Product Name: epoetin beta [NeoRecormon] [epoetin beta]
Date of Report: 22.08.2007
Phase: IV
-
Protocol Number: ML21208
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 21.10.2011
Phase: III
-
Protocol Number: BH17847
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.05.2009
Phase: III
-
Protocol Number: BA17283
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA16740
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA17284
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA16739
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: ML18217
Product Name: epoetin beta [epoetin beta]
Date of Report: 26.01.2009
Phase: IV
-
Protocol Number: ML19553
Product Name: epoetin beta [epoetin beta]
Date of Report: 18.12.2006
Phase: IV
-
Protocol Number: ML20884
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 15.12.2010
Phase: III
-
Protocol Number: MA17502
Product Name: NeoRecormon [epoetin beta [NeoRecormon]]
Date of Report: 26.02.2008
Phase: IV
-
Protocol Number: ML22014
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML21797
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 30.04.2011
Phase: III
-
Protocol Number: ML20752
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.12.2011
Phase: III
-
Protocol Number: ML21810
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report:
Phase: IV
-
Protocol Number: ML21822
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report:
Phase: IV
-
Protocol Number: ML21904
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20680
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML21058
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML21736
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: IV
-
Protocol Number: BH21260
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML21060
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: NH19707
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: II
A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis.
-
Protocol Number: ML20977
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.
-
Protocol Number: ML21096
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
-
Protocol Number: ML25300
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia
-
Protocol Number: ML25276
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25289
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20952
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
A Study of Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia.
-
Protocol Number: BA16558
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: II
-
Protocol Number: NA17101
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: II
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
-
Protocol Number: NH19960
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: II
-
Protocol Number: BA16728
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: II
A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
-
Protocol Number: ML21983
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: IV
A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
-
Protocol Number: ML21524
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML22299
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML18055
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Hematologic Malignancies.
-
Protocol Number: ML18054
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy.
-
Protocol Number: ML20201
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
-
Protocol Number: ML20828
Product Name: NeoRecormon [epoetin beta]
Date of Report: 23.02.2007
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
-
Protocol Number: ML18275
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Patients With Solid Tumors or Hematologic Malignancies
-
Protocol Number: ML20200
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
-
Protocol Number: ML17249
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
-
Protocol Number: ML21145
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML22285
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: IV
A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis
-
Protocol Number: ML21467
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML21146
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20937
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20944
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20978
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients.
-
Protocol Number: NH20052
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: MH21299
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 14.12.2007
Phase: IV
-
Protocol Number: ML25754
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML20197
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML17777
Product Name: epoetin beta
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML21906
Product Name: Epoetin beta
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25067
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25368
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25475
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25465
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22643
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22714
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25476
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25617
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25701
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25362
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
An Observational Study of NeoRecormon (Epoetin beta) in Anemic Patients With Non-myeloid Malignancy
-
Protocol Number: ML22733
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)
-
Protocol Number: ML20888
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 13.04.2011
Phase: III
-
Protocol Number: ML20881
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 01.03.2011
Phase: III
-
Protocol Number: ML21362
Product Name: epoetin beta [NeoRecormon] [epoetin beta]
Date of Report: 06.11.2012
Phase: IV
-
Protocol Number: BA16528
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 26.05.2005
Phase: II
-
Protocol Number: ML17435
Product Name: epoetin beta [epoetin beta]
Date of Report: 10.10.2008
Phase: III
-
Protocol Number: ML17617
Product Name: epoetin beta [epoetin beta]
Date of Report: 01.09.2006
Phase: IV
-
Protocol Number: ML17503
Product Name: epoetin beta [epoetin beta]
Date of Report: 30.01.2009
Phase: II
-
Protocol Number: ML18185
Product Name: epoetin beta [epoetin beta]
Date of Report: 06.12.2007
Phase: IV
-
Protocol Number: ML19382
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report:
Phase: III
-
Protocol Number: ML18028
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.03.2007
Phase: II
-
Protocol Number: ML20659
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 01.06.2011
Phase: III
-
Protocol Number: BH18387
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.11.2010
Phase: III
-
Protocol Number: ML17850
Product Name: NeoRecormon [epoetin beta]
Date of Report: 28.10.2005
Phase: II
-
Protocol Number: BA16285
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: II
-
Protocol Number: BA16286
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: II
-
Protocol Number: BH20051
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta [Mircera]]
Date of Report: 01.08.2011
Phase: III
-
Protocol Number: BA16736
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA16738
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BH20198
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.08.2007
Phase: III
-
Protocol Number: ML21438
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML20826
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML21421
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
-
Protocol Number: ML17620
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.12.2006
Phase: III
-
Protocol Number: ML17616
Product Name: NeoRecormon [epoetin beta]
Date of Report: 18.12.2006
Phase: III
-
Protocol Number: ML18730
Product Name: epoetin beta [epoetin beta]
Date of Report: 11.03.2009
Phase: IV
-
Protocol Number: ML21420
Product Name: NeoRecormon [epoetin beta [NeoRecormon]]
Date of Report: 28.02.2012
Phase: IV
-
Protocol Number: ML22911
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine
-
Protocol Number: ML18042
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.07.2006
Phase: IV
-
Protocol Number: ML18041
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.08.2006
Phase: IV
-
Protocol Number: ML18183
Product Name: epoetin beta [epoetin beta]
Date of Report: 01.03.2009
Phase: III
-
Protocol Number: BA16756
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.05.2006
Phase: III
-
Protocol Number: ML20572
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report: 15.05.2009
Phase: III
-
Protocol Number: BA16169
Product Name: NeoRecormon [epoetin beta]
Date of Report: 02.05.2005
Phase: III
-
Protocol Number: ML21439
Product Name: Mircera [methoxy polyethylene glycol-epoetin beat]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML21040
Product Name: methoxy polyethylene glycol-epoetin beta
Date of Report: To be Published
Phase: III
STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients
-
Protocol Number: ML21348
Product Name: methoxy polyethylene glycol-epoetin beta [Mircera] [methoxy polyethylene glycol-epoetin beta]
Date of Report: 28.06.2010
Phase: IV
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.